KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Cash from Operations (2019 - 2025)

Historic Cash from Operations for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $76.0 million.

  • GoodRx Holdings' Cash from Operations fell 1247.84% to $76.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $179.8 million, marking a year-over-year increase of 1596.08%. This contributed to the annual value of $183.9 million for FY2024, which is 3297.37% up from last year.
  • Latest data reveals that GoodRx Holdings reported Cash from Operations of $76.0 million as of Q3 2025, which was down 1247.84% from $49.6 million recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Cash from Operations registered a high of $86.9 million during Q3 2024, and its lowest value of $9.4 million during Q1 2025.
  • For the 5-year period, GoodRx Holdings' Cash from Operations averaged around $41.2 million, with its median value being $42.6 million (2024).
  • Examining YoY changes over the last 5 years, GoodRx Holdings' Cash from Operations showed a top increase of 41108.13% in 2025 and a maximum decrease of 7789.65% in 2025.
  • Quarter analysis of 5 years shows GoodRx Holdings' Cash from Operations stood at $49.8 million in 2021, then plummeted by 36.0% to $31.9 million in 2022, then crashed by 50.22% to $15.9 million in 2023, then surged by 181.97% to $44.7 million in 2024, then soared by 69.91% to $76.0 million in 2025.
  • Its Cash from Operations stands at $76.0 million for Q3 2025, versus $49.6 million for Q2 2025 and $9.4 million for Q1 2025.